UBS Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.83M | Buy |
231,036
+14,505
| +7% | +$429K | ﹤0.01% | 2784 |
|
|
2025
Q1 | $6.46M | Buy |
216,531
+16,014
| +8% | +$478K | ﹤0.01% | 2754 |
|
|
2024
Q4 | $5.74M | Buy |
200,517
+164,296
| +454% | +$4.71M | ﹤0.01% | 2859 |
|
|
2024
Q3 | $1.4M | Buy |
36,221
+12,948
| +56% | +$500K | ﹤0.01% | 3307 |
|
|
2024
Q2 | $749K | Sell |
23,273
-8,328
| -26% | -$268K | ﹤0.01% | 3634 |
|
|
2024
Q1 | $1.23M | Buy |
31,601
+28,428
| +896% | +$1.1M | ﹤0.01% | 3409 |
|
|
2023
Q4 | $97.7K | Buy |
3,173
+475
| +18% | +$14.6K | ﹤0.01% | 4988 |
|
|
2023
Q3 | $60.3K | Sell |
2,698
-8,798
| -77% | -$197K | ﹤0.01% | 5050 |
|
|
2023
Q2 | $247K | Buy |
11,496
+1,685
| +17% | +$36.2K | ﹤0.01% | 4320 |
|
|
2023
Q1 | $235K | Buy |
9,811
+7,816
| +392% | +$188K | ﹤0.01% | 4232 |
|
|
2022
Q4 | $46.3K | Sell |
1,995
-1,561
| -44% | -$36.2K | ﹤0.01% | 5684 |
|
|
2022
Q3 | $57K | Buy |
3,556
+2,667
| +300% | +$42.8K | ﹤0.01% | 5143 |
|
|
2022
Q2 | $16K | Sell |
889
-950
| -52% | -$17.1K | ﹤0.01% | 6146 |
|
|
2022
Q1 | $37K | Sell |
1,839
-1,263
| -41% | -$25.4K | ﹤0.01% | 5758 |
|
|
2021
Q4 | $58K | Sell |
3,102
-943
| -23% | -$17.6K | ﹤0.01% | 5671 |
|
|
2021
Q3 | $79K | Sell |
4,045
-11,846
| -75% | -$231K | ﹤0.01% | 4914 |
|
|
2021
Q2 | $376K | Sell |
15,891
-3,421
| -18% | -$80.9K | ﹤0.01% | 3935 |
|
|
2021
Q1 | $458K | Buy |
19,312
+3,961
| +26% | +$93.9K | ﹤0.01% | 3993 |
|
|
2020
Q4 | $308K | Buy |
15,351
+10,489
| +216% | +$210K | ﹤0.01% | 4001 |
|
|
2020
Q3 | $102K | Sell |
4,862
-14,222
| -75% | -$298K | ﹤0.01% | 4335 |
|
|
2020
Q2 | $334K | Sell |
19,084
-3,655
| -16% | -$64K | ﹤0.01% | 3660 |
|
|
2020
Q1 | $372K | Sell |
22,739
-27,522
| -55% | -$450K | ﹤0.01% | 3451 |
|
|
2019
Q4 | $1.03M | Buy |
50,261
+20,811
| +71% | +$428K | ﹤0.01% | 3309 |
|
|
2019
Q3 | $338K | Buy |
29,450
+26,680
| +963% | +$306K | ﹤0.01% | 3992 |
|
|
2019
Q2 | $36K | Sell |
2,770
-1,850
| -40% | -$24K | ﹤0.01% | 5316 |
|
|
2019
Q1 | $70K | Sell |
4,620
-3,619
| -44% | -$54.8K | ﹤0.01% | 4516 |
|
|
2018
Q4 | $141K | Sell |
8,239
-215
| -3% | -$3.68K | ﹤0.01% | 4373 |
|
|
2018
Q3 | $124K | Sell |
8,454
-60,564
| -88% | -$888K | ﹤0.01% | 4541 |
|
|
2018
Q2 | $1.65M | Sell |
69,018
-132,940
| -66% | -$3.17M | ﹤0.01% | 2687 |
|
|
2018
Q1 | $5.16M | Buy |
201,958
+51,204
| +34% | +$1.31M | ﹤0.01% | 1830 |
|
|
2017
Q4 | $2.78M | Buy |
150,754
+139,824
| +1,279% | +$2.58M | ﹤0.01% | 2272 |
|
|
2017
Q3 | $114K | Sell |
10,930
-10,374
| -49% | -$108K | ﹤0.01% | 4372 |
|
|
2017
Q2 | $267K | Buy |
21,304
+7,537
| +55% | +$94.5K | ﹤0.01% | 3733 |
|
|
2017
Q1 | $139K | Buy |
13,767
+10,174
| +283% | +$103K | ﹤0.01% | 4028 |
|
|
2016
Q4 | $56K | Buy |
3,593
+175
| +5% | +$2.73K | ﹤0.01% | 4820 |
|
|
2016
Q3 | $66K | Buy |
3,418
+418
| +14% | +$8.07K | ﹤0.01% | 4429 |
|
|
2016
Q2 | $36K | Sell |
3,000
-1,500
| -33% | -$18K | ﹤0.01% | 4913 |
|
|
2016
Q1 | $82K | Buy |
4,500
+2,208
| +96% | +$40.2K | ﹤0.01% | 4349 |
|
|
2015
Q4 | $63K | Buy |
2,292
+1,792
| +358% | +$49.3K | ﹤0.01% | 4573 |
|
|
2015
Q3 | $11K | Buy |
+500
| New | +$11K | ﹤0.01% | 5859 |
|